Navigation Links
Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
Date:5/5/2009

TAMPA, Fla., May 5 /PRNewswire-USNewswire/ -- The Tampa Lions Eye Institute for Transplant and Research, Inc. (LEITR) today announced plans to open a new 12,000-square-foot facility in Tampa, Florida. This state-of-the-art facility will offer high-volume, high-quality human ocular tissue for research, study, collaboration, and clinical advancements, as well as extensive space for on-site residence, sleeping quarters, and meetings/events.

This marks an expansion of the current 35,000 square-foot Tampa Eye Bank facility, already the world's largest eye bank. This new model -- a Research Institute built within an eye bank -- is believed to be the first of its kind in the world.

For more than 30 years, LEITR has provided over 30,000 corneas for transplant and 50,000 eyes for research worldwide. LEITR recognized that research into blinding diseases had to be greatly expanded, particularly due to the exponential growth and incidence of macular degeneration and glaucoma. "The LEITR expansion means that, for the first time, diseased as well as healthy human eye tissue will be available to us for research," says Dr. Henry Edelhauser, Ferst Professor at Emory University Eye Center. "This availability of a full spectrum of human eye tissue will improve our understanding of the underlying events that lead to blindness. Even more importantly, what we learn will eventually have a tremendous, positive impact on quality of life for patients with blinding diseases."

Transforming Ocular Research

Key to the successful advancement of ocular tissue research is having the highest quality human tissue available. Over the years, LEITR recognized that time between tissue donor death and tissue recovery was essential. Current methods of providing tissue, particularly overnight shipping to facilities, has greatly affected the quality of that tissue. Now, researchers will have a repository of high-quality human ocular tissue on site at LEITR.

Racing Against Time

As the U.S. population ages, the prevalence of macular degeneration and glaucoma have affected millions of Americans. Macular degeneration is the leading cause of visual loss in the elderly and the condition profoundly affects their quality of life. Glaucoma, affecting upwards of 3 million Americans, contributes to over 120,000 new cases of blindness each year and is the leading cause of blindness among African Americans. LEITR's initial research platforms will explore the leading causes of these two blinding diseases, providing diseased or compromised eyes for advancing research in these disease areas.

LEITR is also forming a distinguished advisory board, consisting of thought leaders from top academic eye institutions around the country. Collaborative relationships with academic, government, and pharmaceutical industry research centers will be established to facilitate accelerated drug innovation, timely clinical trials, and a foundation for best research practices.

The LEITR Mission

"Our stated mission is to set new standards for ocular research that will improve visual outcomes and quality of life for those who are blind or visually impaired," says Jason K. Woody, Executive Director and CEO of LEITR. "We intend to be the new pioneers of ocular research."

About LEITR

LEITR is a non-profit, charitable organization dedicated to the recovery, evaluation, and distribution of eye tissue for transplantation, research, and education. The eye institute is one of the largest in the world. Since its inception, it has brought the "Gift of Sight" to over 20,000 men, women, and children worldwide. LEITR was founded by a group of Tampa Lions in 1973. Since the beginning, the eye institute has been guided by a board of directors comprised of Lions and prominent ophthalmic specialists and surgeons. For more information call Jason K. Woody at 1-813-289-1200, visit our Web site at www.lionseyeinstitute.org.


'/>"/>
SOURCE Lions Eye Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
2. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
3. Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
4. Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
5. Midwest Research Institute Launches Clinical Molecular Diagnostics Laboratory
6. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
7. Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
8. Roskamp Institute Identifies New Class of Drugs to Treat Alzheimers Disease
9. Open Letter to President-Elect Barack Obama From Don Margolis, Chairman and Founder of The Repair Stem Cell Institute
10. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
11. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Community pharmacists can help improve ... the pharmacy through a custom-built medication synchronization program, Cardinal ... and owner at Schieber Family Pharmacy in ... a lot of patients enrolled in this medication synchronization ... a win for the patient, and it,s a win ...
(Date:2/11/2016)... DIEGO , Feb. 11, 2016 ... groundbreaking cell-isolation method that opens the door to ... until now have been impossible to isolate with ... to isolate specific tumor types in various stages ... genetic variants of these cells that are clinically ...
(Date:2/11/2016)... 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) announced ... February 25 at 11:30 a.m. Eastern Time to discuss its ... www.ionispharma.com . A webcast replay will be ... --> www.ionispharma.com . A webcast replay will be available ... Interested parties may listen to the call by dialing ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Registered nurses, licensed practical ... seminar titled, “Stroke Management: Time to Act, Time to Heal” on Thursday, February 25 ... Whippany, N.J. The presenter is Vishal Chedda, president of ANSA Consultants, who will discuss ...
(Date:2/11/2016)... ... 2016 , ... Florida Hospital presents Heart Health Awareness night on Sunday February ... the Amalie Arena. The puck drops at 6:00pm, but fans will have the opportunity ... to the game. The MEGA Heart will be located on Ford Thunder Alley and ...
(Date:2/11/2016)... ... February 11, 2016 , ... Image One USA veteran franchise owner ... it’s the buildings of Nashville that will benefit. , “I’ve enjoyed being a part ... Nashville, there was no question that I would bring my business with me,” Bogacki ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... the healthcare industry, ranked among the top five firms in the “2015/2016 Best ... HIT Implementation Support and Staffing. KLAS is a research and insights firm on ...
(Date:2/11/2016)... Petersburg, FL (PRWEB) , ... February 11, 2016 ... ... providers and advocates will discuss how to improve care by making data on ... pediatric heart disease. The Summit on Transparency and Public Reporting of Pediatric and ...
Breaking Medicine News(10 mins):